Telomir Pharmaceuticals, Inc. (NASDAQ:TELO), or the “Company”, an emerging leader in age-reversal science, today announced significant findings from its copper binding studies with Telomir-1. This is ...
Researchers from Israel, Italy, Portugal, and the Netherlands have developed an innovative technology to enable co-delivery of two different drugs to the tumor site, Tel Aviv University said in a ...